AbCellera director Sandor Victor files Form 3

AbCellera Biologics Inc. filed an initial ownership report for Sandor Victor.

Rhea-AI Filing Summary

AbCellera Biologics Inc. filed an initial ownership report for Sandor Victor. The filing identifies him as a director of the company, not an officer and not a ten percent owner. This Form 3 does not report any share transactions or holdings, serving only as a baseline disclosure.

Key Terms

Form 3, director, ten percent owner

3 terms

Form 3 regulatory

"This Form 3 does not report any share transactions or holdings"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

director financial

"The filing identifies him as a director of the company"

ten percent owner regulatory

"not an officer and not a ten percent owner"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does AbCellera Biologics (ABCL) disclose in Sandor Victor’s Form 3?

The Form 3 identifies Sandor Victor as a director of AbCellera Biologics Inc. It serves as an initial ownership report and, in this case, shows no reported transactions or holdings, providing only baseline information about his status as an insider.

Does the Sandor Victor Form 3 for AbCellera (ABCL) show any share transactions?

No, the Form 3 for Sandor Victor reports zero buy, sell, acquisition, or disposition transactions. The transaction summary shows no shares traded and no derivative activity, indicating this filing is purely a status and initial ownership disclosure without trading details.

Is Sandor Victor a ten percent owner of AbCellera Biologics (ABCL)?

The Form 3 indicates Sandor Victor is not a ten percent owner of AbCellera Biologics Inc. He is reported solely in the role of director, and the filing does not attribute to him any ownership position meeting the ten percent holder classification threshold.

Does the AbCellera (ABCL) Form 3 for Sandor Victor include derivative positions?

No, the Form 3 derivative summary is empty for Sandor Victor. It shows no options, warrants, or other derivative securities reported and lists zero derivative transactions, so there is no remaining derivative position disclosed in this particular filing.

What is the significance of a Form 3 filing like AbCellera’s for Sandor Victor?

A Form 3 establishes that an individual is now an insider, such as a director, and provides baseline ownership information. For Sandor Victor at AbCellera, it confirms his director role but reports no transactions or holdings, offering a starting point for future Form 4 updates.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/11/2026 - 01:49 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Sandor Victor

(Last) (First) (Middle)

C/O ABCELLERA BIOLOGICS INC

150 W 4TH AVENUE

(Street)

VANCOUVER

(City) (State) (Zip)

BRITISH COLUMBIA, CANADA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/01/2026

3. Issuer Name and Ticker or Trading Symbol
AbCellera Biologics Inc. [ ABCL ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	Tryn Stimart, attorney-in-fact	06/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)